284 related articles for article (PubMed ID: 17710662)
1. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Berenguer-Potenciano M; Villora-Morcillo N; Nunez-Enamorado N; Perez-Alonso V; Camacho-Salas A; Simon-De Las Heras R
Rev Neurol; 2015 Jan; 60(2):91-2. PubMed ID: 25583593
[No Abstract] [Full Text] [Related]
3. Vincristine induced cranial neuropathy.
Dixit G; Dhingra A; Kaushal D
J Assoc Physicians India; 2012 Mar; 60():56-8. PubMed ID: 22799120
[TBL] [Abstract][Full Text] [Related]
4. Vincristine induced unilateral ptosis.
Dejan S; Dragana B; Ivana P; Borivoje B; Marko P
J Pediatr Hematol Oncol; 2009 Jun; 31(6):463. PubMed ID: 19648799
[No Abstract] [Full Text] [Related]
5. Vincristine induced cranial polyneuropathy.
Bay A; Yilmaz C; Yilmaz N; Oner AF
Indian J Pediatr; 2006 Jun; 73(6):531-3. PubMed ID: 16816519
[TBL] [Abstract][Full Text] [Related]
6. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine.
Müller L; Kramm CM; Tenenbaum T; Wessalowski R; Göbel U
Pediatr Blood Cancer; 2004 Mar; 42(3):287-8. PubMed ID: 14752870
[No Abstract] [Full Text] [Related]
8. Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy.
Akbayram S; Akgun C; Doğan M; Sayin R; Caksen H; Oner AF
Indian J Pediatr; 2010 Jun; 77(6):681-3. PubMed ID: 20532679
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
10. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.
Ngamphaiboon N; Sweeney R; Wetzler M; Wang ES
Leuk Res; 2010 Aug; 34(8):e194-6. PubMed ID: 20167372
[No Abstract] [Full Text] [Related]
12. Vincristine-induced ptosis in a leukemia patient treated with pyridoxine and pyridostigmine.
Johnson L; Johnson J; Philip SM; Thirugnanam R
J Oncol Pharm Pract; 2023 Jul; 29(5):1271-1274. PubMed ID: 36734133
[TBL] [Abstract][Full Text] [Related]
13. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
14. Vincristine-Induced Neuropathy Presenting as Ptosis and Ophthalmoplegia in a 2-Year-Old Boy.
Palkar AH; Nair AG; Desai RJ; Potdar NA; Shinde CA
J Pediatr Ophthalmol Strabismus; 2015 Jul; 52 Online():e34-7. PubMed ID: 26176228
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-induced unilateral ptosis in a child.
Gursel O; Sari E; Altun D; Atay AA; Akin R
Pediatr Neurol; 2009 Dec; 41(6):461-3. PubMed ID: 19931172
[TBL] [Abstract][Full Text] [Related]
16. Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury.
Mahadeo KM; Dhall G; Panigrahy A; Lastra C; Ettinger LJ
Pediatr Hematol Oncol; 2010 Feb; 27(1):46-52. PubMed ID: 20121554
[TBL] [Abstract][Full Text] [Related]
17. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
Griffiths JD; Stark RJ; Ding JC; Cooper IA
Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
19. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy dosing with elevated liver function test results in acute leukemia.
Comeau TB; Phillips DL
Ann Pharmacother; 2005 Oct; 39(10):1752-4. PubMed ID: 16131538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
